Brittany Craiglow
Dermatology · Fairfield, CTNPI 1053554667
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,428,240 of the $1,940,047 with a category attached, or 73.6%. 25 manufacturers reported payments, led by Pfizer at 27.3% of the total. Among dermatology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,343 payments — averaging $1444.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$530K
- Sanofi$408K
- Regeneron Healthcare Solutions, Inc.$369K
- Lilly USA, LLC$295K
- AbbVie$114K
- Eli Lilly$92K
- plus $132K from 19 others
Across 11 payments — averaging $990.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$11K
What the payments were for
- Consulting fees$345,09618%
- Speaking & faculty fees$1,428,24074%
- Travel & lodging$143,7737%
- Food & beverage$22,9341%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 241 | $530,171 |
| Sanofi | 265 | $408,466 |
| Regeneron Healthcare Solutions, Inc. | 295 | $368,707 |
| Lilly USA, LLC | 267 | $294,638 |
| AbbVie | 95 | $114,440 |
| Eli Lilly | 44 | $91,932 |
| Incyte Corporation | 63 | $59,965 |
| Dermavant Sciences, Inc. | 20 | $26,373 |
| Sun Pharmaceutical Industries Inc. | 8 | $17,932 |
| Arcutis Biotherapeutics, Inc. | 5 | $9,083 |
| Aclaris Therapeutics, Inc. | 5 | $5,554 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $4,150 |
| LEO Pharma AS | 1 | $2,600 |
| LEO Pharma Inc. | 11 | $2,475 |
| GSK | 1 | $1,700 |
| Novartis | 6 | $1,554 |
| Sanofi-aventis U.S. LLC | 5 | $157 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| UCB, Inc. | 1 | $16 |
| Organon | 2 | $16 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,940,047 in reported general payments places this provider in the 95th percentile of 222 dermatology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 19 | $836 |
| Spironolactone | 14 | $439 |
| Dutasteride | 12 | $301 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fairfield
- Brett KingFairfield$2.5M
- Michael PayetteCromwell$3.2M
- Bruce StroberCromwell$2.9M
- Mona ShahriariCromwell$2.2M
- Jeremy MossMadison$2M
- Meagen McCuskerEnfield$1.8M
- Marcus McFerrenOrange$872K
- Christopher BunickNew Haven$661K
- Keith ChoateNew Haven$362K
- Kim NicholsGreenwich$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.